A NUMBER OF ETHICAL QUESTIONS THAT WE HAVE TO CAREFULLY CONSIDER AND THIS IS WHY I AND MY COLLEAGUES HAVE CALLED FOR A GLOBAL PAUSE IN ANY CLINICAL APPLICATION OF THE CRISPR TECHNOLOGY IN HUMAN EMBRYOS TO GIVE US TIME TO